These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16405017)

  • 1. [Expression of E-cadherine as a differential diagnostic fest for lobular infiltrative breast cancers].
    Chipysheva TA; Ermilova VD; Vishnevskaia IaV; Vasil'ev IuM
    Arkh Patol; 2005; 67(6):24-7. PubMed ID: 16405017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
    Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
    Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma.
    Wahed A; Connelly J; Reese T
    Ann Diagn Pathol; 2002 Dec; 6(6):349-51. PubMed ID: 12478484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the level of E-cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastases?
    Goldstein NS
    Am J Clin Pathol; 2002 Sep; 118(3):425-34. PubMed ID: 12219785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
    Moll R; Mitze M; Frixen UH; Birchmeier W
    Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
    De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM
    J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of cell adhesion molecules E-cadherin and beta-catenin in infiltrating breast carcinoma].
    Chipysheva TA; Gel'shteĭn VI; Ermilova VD; Vishnevskaia IaV; Vasil'ev IuM
    Arkh Patol; 2003; 65(3):3-7. PubMed ID: 12879601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma.
    Lehr HA; Folpe A; Yaziji H; Kommoss F; Gown AM
    Am J Clin Pathol; 2000 Aug; 114(2):190-6. PubMed ID: 10941333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.
    Palacios J; Benito N; Pizarro A; Suárez A; Espada J; Cano A; Gamallo C
    Am J Pathol; 1995 Mar; 146(3):605-12. PubMed ID: 7534041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast.
    Palacios J; Sarrió D; García-Macias MC; Bryant B; Sobel ME; Merino MJ
    Mod Pathol; 2003 Jul; 16(7):674-8. PubMed ID: 12861063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Importance of E-cadherin; expression in the inmunohistochemical diagnosis of breast cancer].
    García Tamayo J; Blasco Olaetxea E; Morales A; Molina J; Guzmán Bistoni C; Méndez V
    Invest Clin; 2006 Dec; 47(4):371-83. PubMed ID: 17176905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
    Rakha EA; Abd El Rehim D; Pinder SE; Lewis SA; Ellis IO
    Histopathology; 2005 Jun; 46(6):685-93. PubMed ID: 15910600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistological localisation of human FAT1 (hFAT) protein in 326 breast cancers. Does this adhesion molecule have a role in pathogenesis?
    Kwaepila N; Burns G; Leong AS
    Pathology; 2006 Apr; 38(2):125-31. PubMed ID: 16581652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse growth pattern affects E-cadherin expression in invasive breast cancer.
    Brinck U; Jacobs S; Neuss M; Tory K; Rath W; Kulle B; Füzesi L
    Anticancer Res; 2004; 24(4):2237-42. PubMed ID: 15330167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas: relation to E-cadherin alterations, proliferative activity, and ploidy of the tumors.
    Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Markopoulos C; Gogas J; Kittas C
    Cancer; 2002 May; 94(9):2454-65. PubMed ID: 12015771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions.
    Goldstein NS; Bassi D; Watts JC; Layfield LJ; Yaziji H; Gown AM
    Am J Clin Pathol; 2001 Apr; 115(4):534-42. PubMed ID: 11293901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma.
    Rasbridge SA; Gillett CE; Sampson SA; Walsh FS; Millis RR
    J Pathol; 1993 Feb; 169(2):245-50. PubMed ID: 8383197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters.
    Qureshi HS; Linden MD; Divine G; Raju UB
    Am J Clin Pathol; 2006 Mar; 125(3):377-85. PubMed ID: 16613340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.